Your browser doesn't support javascript.
loading
Clinically important pharmacokinetic drug-drug interactions with antibacterial agents.
Torrent Rodríguez, A; Font I Barceló, A; Barrantes González, M; Echeverria Esnal, D; Soy Muner, D; Martínez, J A; Tuset Creus, M.
Affiliation
  • Torrent Rodríguez A; Arnau Torrent-Rodríguez,Hospital Clínic de Barcelona, Carrer Villarroel 170, 08036, Barcelona, Cataluña, Spain. atorrentr@clinic.cat.
Rev Esp Quimioter ; 37(4): 299-322, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38840420
ABSTRACT
Antimicrobial agents are widely used, and drug interactions are challenging due to increased risk of adverse effects or reduced efficacy. Among the interactions, the most important are those affecting metabolism, although those involving drug transporters are becoming increasingly known. To make clinical decisions, it is key to know the intensity of the interaction, as well as its duration and time-dependent recovery after discontinuation of the causative agents. It is not only important to be aware of all patient treatments, but also of supplements and natural medications that may also interact. Although they can have serious consequences, most interactions can be adequately managed with a good understanding of them. Especially in patients with polipharmacy it is compulsory to check them with an electronic clinical decision support database. This article aims to conduct a narrative review focusing on the major clinically significant pharmacokinetic drug-drug interactions that can be seen in patients receiving treatment for bacterial infections.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Interactions / Anti-Bacterial Agents Limits: Humans Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Interactions / Anti-Bacterial Agents Limits: Humans Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: